Epygen Biotech, first company in India to acquire licensing of Novel Biological Entity (NBE)
The company has acquired the exclusive licensing of NBE from CSIR-IMTECH for treatment of Ischemic strokes
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Morepen Labs begins FY 2018-19 with sound performance in first quarter
Company reports 93 percent rise in its consolidated net profit and 26 percent rise in its consolidated net sales revenue in Q1 of…
Indoco declares Q1FY19 results
Indoco Remedies posted revenues of INR 212.5 crores during the first quarter of FY 2018-19, as against INR 204.2 crores, for the…
Pharma market grows by 12.7 per cent in July 2018
In July, growth due to price was a positive contributor, unlike previous months, when price growth was a negative factor
Benzodiazepines associated with increased risk of Alzheimer’s disease: Study
The medication is commonly used for sleep problems, but its effectiveness for this indication diminishes over weeks or months
Dr R Ananthanarayanan appointed as Cipla’s global COO
He will oversee R&D, manufacturing, supply chain, the API business and the key geographies of North America, Europe and…
Glenmark enters in collaboration with True North
As part of the arrangement, Glenmark’s orthopaedic and pain management business in India and Nepal will be transferred to a new…
Cipla partners with MSN Laboratories for marketing, distribution of generic Xeloda
Capecitabine tablets are indicated as a single agent for adjuvant treatment in patients with Dukes C colon cancer
Multipurpose stalls at railways stations sell generic low-cost medicine
In a written reply in Lok Sabha, Minister of State for Railways, Rajen Gohain said at present, three chemist stalls are…
Hester Biosciences Q1FY19 results: Sales up by 32%, profitability up by 57%
The main drivers for the improvement were reduction in the costs of goods sold and better inventory management
AstraZeneca receives marketing permission for Osimertinib to treat non-small cell lung cancer in…
Osimertinib (TagrissoTM) will be used as 1st line treatment for NSCLC offering potential new standard of care
ACG Inspection partners with Verinetics to further strengthen fight against falsified medicines
With this partnership, ACG Inspections is looking to implement an add-on security layer to provide Multi-Factor authentication to…
Novo Nordisk Pharmatech in agreement with Signet Chemical Corporation
The agreement will lead to the distribution of pharmaceutical range of quaternary ammonium compounds to the healthcare industry in…
Consulate General of Canada, PHARMEXCIL, Trade & Invest British Columbia host roadshow in…
The day-long session in Mumbai consisted of presentations from top Canadian pharmaceutical companies
China orders recall of defective vaccines
The recall indicated the scandal gripping China may have spread to foreign markets, dealing a potentially heavy blow to the…
Glenmark bags FDA acceptance for Ryaltris
The drug is used for patients suffering from seasonal allergic rhinitis
Kilitch Drugs eyes African markets
To set up manufacturing unit on 12400 sq mt of land in Ethiopia
Merck Q2 net profit jumps over 2-fold to ₹ 48 crore
The company had posted a net profit of ₹ 20.12 crore for the corresponding period of the previous fiscal
Glenmark’s partner Elite Pharmaceuticals receives US FDA approval
The company received approval for abbreviated new drug application for methadone hydrochloride 5 mg and 10 mg tablets